← PREVIOUS POSTGlycotest’s Coverage of Key Biomarker Fucosylated Kininogen Extended by European Patent. NEXT POST →Glycotest Announces Start of Enrollment in Its Case-Control Study of the HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma (NCT03878550).